Lupus Remission Linked to Better Pregnancy Outcomes
A prospective study of 107 pregnancies in women with systemic lupus erythematosus (SLE) suggests that achieving disease remission is critical for reducing adverse pregnancy outcomes. The research highlights that high-risk patients often excluded from previous studies face significant complications, emphasizing the need for broader clinical assessment.
Why it matters
This study provides vital clinical guidance for managing high-risk pregnancies in patients with autoimmune conditions, potentially improving neonatal and maternal health outcomes.
WOMEN with systemic lupus erythematosus (SLE) who are not in remission may face an increased risk of adverse pregnancy outcomes, according to findings from a prospective cohort study examining pregnancy complications across different disease severity groups.
Researchers found that adverse pregnancy outcome rates varied substantially depending on patient characteristics and the definitions used to classify complications. The findings also highlighted the potential importance of achieving disease remission before pregnancy, particularly among women with additional clinical risk factors.
SLE is associated with an increased risk of pregnancy complications, including preterm birth, pre-eclampsia, pregnancy loss, and adverse neonatal outcomes.
Previous research, particularly the Predictors of Pregnancy Outcomes: Biomarkers in Antiphospholipid Syndrome and SLE (PROMISSE) study, has established important benchmarks for pregnancy outcomes in women with SLE.
However, PROMISSE excluded certain high-risk patients and used relatively narrow definitions of adverse pregnancy outcomes, potentially underestimating the burden of complications across the broader SLE population.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in